Heron Therapeutics Narrows FY24 Guidance For Product Revenues, Net, Adjusted Operating Expenses, And Adjusted EBITDA
Heron Therapeutics Narrows FY24 Guidance For Product Revenues, Net, Adjusted Operating Expenses, And Adjusted EBITDA
Heron Therapeutics縮小了FY24產品收入、淨額、調整後營業費用和調整後EBITDA的指引
Heron Therapeutics Narrows FY24 Guidance For Product Revenues, Net, Adjusted Operating Expenses, And Adjusted EBITDA
Heron Therapeutics縮小了FY24產品收入、淨額、調整後營業費用和調整後EBITDA的指引
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。